Back

Long-term QT interval analysis for real world patients with Insertable cardiac monitors taking antiarrhythmic drugs

8 April 2024 (09:30 - 10:15)
Organised by: Logo
Congress Presentation Part of: Arrhythmias 8: atrial fibrillation Implantable Loop Recorder EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Ms Maudeline Deus

Medtronic, Inc., Minneapolis (United States of America)

7 More presentations in this session

Presentation thumbnail
Non-alcoholic fatty liver disease in patients with atrial fibrillation: a report from a global federated health network.
Doctor T. Bucci (Perugia, IT)
Abstract Slides Video
Presentation thumbnail
Prevention of venous thromboembolism after right heart-sided electrophysiological procedures: results of an EHRA survey
Doctor G. Mugnai (Verona, IT)
Abstract Slides Video
Presentation thumbnail
Left atrial posterior wall isolation during catheter ablation with the pulsed field ablation in patients with persistent atrial fibrillation
Doctor M. Schiavone (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Endocardial ablation of ganglionated plexus for the treatment of carotid sinus syndrome
Doctor C. Minguito Carazo (A Coruna, ES)
Abstract Slides Video
Presentation thumbnail
Useful aid or futile hassle - continuous rhythm monitoring following acute myocardial infarction
Mr L. Hamacher (Vienna, AT)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias 8: atrial fibrillation

The Event

Event poster

EHRA 2024

8 April 2024 09:30 CET
You may be interested in
thumbnail
Congress Presentation
Continuous QTc interval trends in male and female patient groups with implanted insertable cardiac monitors undergoing antiarrhythmic drug loading
thumbnail
Congress Presentation
Dynamic QTc interval changes observed in real-world patients with implanted insertable cardiac monitors taking class III antiarrhythmic drugs
thumbnail
Congress Presentation
Continuous QT interval monitoring using insertable cardiac monitors during antiarrhythmic loading hospitalization: Results from the "LINQ QT" Study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources